Man Group
RNAC icon

Man Group’s Cartesian Therapeutics RNAC Stock Holding History

Man Group’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,699
Closed -$146K – 2570
2026
Q1 		$146K Buy
+23,699
New +$169K ﹤0.01% 2330
2023
Q1 		– Sell
-5,206
Closed -$245K – 1719
2022
Q4 		$176K Buy
5,206
+667
+15% +$28.4K ﹤0.01% 1800
2022
Q3 		$223K Buy
+4,539
New +$249K ﹤0.01% 1746
2022
Q2 		– Hold
0
– – – 1940
2022
Q1 		– Sell
-6,000
Closed -$587K – 2335
2021
Q4 		$587K Buy
6,000
+20
+0.3% +$2.15K ﹤0.01% 1483
2021
Q3 		$746K Buy
5,980
+799
+15% +$96.5K ﹤0.01% 1436
2021
Q2 		$650K Sell
5,181
-1,891
-27% -$225K ﹤0.01% 1494
2021
Q1 		$960K Sell
7,072
-2,444
-26% -$303K ﹤0.01% 1302
2020
Q4 		$865K Buy
9,516
+1,669
+21% +$145K ﹤0.01% 1449
2020
Q3 		$584K Buy
7,847
+3,069
+64% +$235K ﹤0.01% 1518
2020
Q2 		$407K Buy
4,778
+3,491
+271% +$316K ﹤0.01% 1500
2020
Q1 		$93K Sell
1,287
-27,418
-96% -$2.65M ﹤0.01% 1521
2019
Q4 		$2.05M Sell
28,705
-92,418
-76% -$4.46M 0.01% 1325
2019
Q3 		$6.36M Sell
121,123
-763
-0.6% -$40.5K 0.02% 759
2019
Q2 		$6.54M Buy
121,886
+217
+0.2% +$14.8K 0.02% 840
2019
Q1 		$8.65M Buy
121,669
+103,854
+583% +$6.58M 0.03% 655
2018
Q4 		$1.42M Buy
17,815
+9,238
+108% +$2.11M 0.01% 1340
2018
Q3 		$4M Buy
8,577
+4,989
+139% +$2M 0.01% 1113
2018
Q2 		$1.43M Buy
+3,588
New +$1.27M 0.01% 1492

Other funds holding RNAC

Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Man Group's RNAC Position: Q2 2026 in Review

Man Group sold out of Cartesian Therapeutics (RNAC) in Q2 2026, closing a stake of 23,699 shares — an estimated $146K sold.

Man Group first reported a position in RNAC in Q2 2018 and held it in 18 quarters. The position peaked at $8.65M in Q1 2019. 95 funds tracked by Wall St. Rank hold RNAC as of Q2 2026.

  • Man Group reported no remaining Cartesian Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Man Group sold 23,699 Cartesian Therapeutics shares in Q2 2026, an estimated $146K.
  • Man Group first reported a position in Cartesian Therapeutics in Q2 2018 and held it in 18 quarters.
  • Man Group's Cartesian Therapeutics position peaked at $8.65M in Q1 2019.
  • 95 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.